Scott D L, Greenwood A, Davies J, Maddison P J, Maddison M C, Hall N D
Department of Rheumatology, St Bartholomew's Hospital, West Smithfield, London.
Br J Rheumatol. 1990 Apr;29(2):126-7. doi: 10.1093/rheumatology/29.2.126.
We studied 43 patients with active rheumatoid disease of less than 4 years' duration: 23 were given hydroxychloroquine and 20 penicillamine. Efficacy was assessed using clinical and laboratory variables. Radiological progression was measured using Larsen's method for scoring plain radiographs of the hands and feet. Twenty-four patients received 2 years' continuous therapy. Clinically both drugs were effective with falls in articular index and C-reactive protein. Initial radiological damage was less with penicillamine (P less than 0.05 by Wilcoxon rank sum test). By 2 years there were no significant differences between the two drugs; mean increases in Larsen score were 20.3 with penicillamine and 27.5 with hydroxychloroquine. Both groups progressed at a rate likely to give severe joint destruction over 10-20 years.
我们研究了43例病程少于4年的活动性类风湿病患者:23例给予羟氯喹,20例给予青霉胺。使用临床和实验室指标评估疗效。采用Larsen方法对手足平片进行评分以测量放射学进展。24例患者接受了2年的持续治疗。临床上两种药物均有效,关节指数和C反应蛋白均下降。青霉胺治疗初始时放射学损伤较轻(Wilcoxon秩和检验P<0.05)。到2年时,两种药物之间无显著差异;青霉胺组Larsen评分平均增加20.3,羟氯喹组为27.5。两组进展速度均可能在10至20年内导致严重的关节破坏。